Evofem Biosciences, Inc. held its Annual Meeting on November 26, 2025, where stockholders approved a 1-for-500 to 1-for-1,500 reverse stock split of shares and various board proposals. Approximately 79.5% of eligible votes were cast in favor of the proposals, including electing directors and the 2025 Equity Incentive Plan.